Constitutively active calcineurin mediates delayed neuronal death through Fas-ligand expression via activation of NFAT and FKHR transcriptional activities in mouse brain ischemia

J Neurochem. 2007 Sep;102(5):1506-1517. doi: 10.1111/j.1471-4159.2007.04600.x. Epub 2007 Apr 30.

Abstract

We recently demonstrated that a constitutively active form of calcineurin (CaN) is generated by calpain-mediated limited proteolysis following brain ischemia. The calpain-induced CaN activation mediated delayed neuronal death through translocation of nuclear factor of activated T-cells (NFAT) into nuclei after brain ischemia. We also previously demonstrated that activation of forkhead in rhabdomyosarcoma (FKHR), a forkhead transcription factor and substrate of protein kinase-B (Akt), mediated ischemia-induced neuronal death through Fas-ligand expression in gerbil hippocampus. FKHR activation occurred through decreased Akt activity and concomitant dephosphorylation mediated by undefined phosphatases. In this study, we show that phosphorylated Ser-256 of FKHR is dephosphorylated by constitutively active CaN and that in turn FKHR forms a complex with CaN that is translocated into nuclei after brain ischemia. After nuclear translocation of NFAT and FKHR, both NFAT and FKHR stimulated expression of Fas-ligand by binding to its promoter region. Consistent with activation of the Fas-ligand promoter by FKHR dephosphorylation, Fas-ligand expression increased 2 days after ischemia/reperfusion, and treatment with the CaN inhibitor FK506 inhibited that expression. These results suggest that FKHR is a downstream target of CaN and that constitutively active CaN mediates delayed neuronal death through Fas-ligand expression via up-regulation of both NFAT and FKHR transcriptional activity in brain ischemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Brain Ischemia / drug therapy
  • Brain Ischemia / pathology*
  • Calcineurin / metabolism*
  • Cell Death / drug effects
  • Electrophoretic Mobility Shift Assay / methods
  • Enzyme Activation / drug effects
  • Fas Ligand Protein / metabolism*
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors / metabolism*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology*
  • Immunoprecipitation / methods
  • Immunosuppressive Agents / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • NFATC Transcription Factors / metabolism*
  • Oncogene Protein v-akt / metabolism
  • Phosphorylation / drug effects
  • Protein Transport / drug effects
  • Protein Transport / physiology
  • Serine / metabolism
  • Tacrolimus / pharmacology

Substances

  • Fas Ligand Protein
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors
  • Foxo1 protein, mouse
  • Immunosuppressive Agents
  • NFATC Transcription Factors
  • Serine
  • Oncogene Protein v-akt
  • Calcineurin
  • Tacrolimus